S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.66 (+0.78%)
AAPL   116.60 (+1.35%)
MSFT   213.25 (+1.51%)
FB   283.29 (+2.23%)
GOOGL   1,598.88 (+0.92%)
AMZN   3,286.33 (+2.47%)
TSLA   424.68 (+1.05%)
NVDA   535.87 (+1.94%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   78.88 (-4.07%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.01 (+0.08%)
NFLX   488.93 (+0.14%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.66 (+0.78%)
AAPL   116.60 (+1.35%)
MSFT   213.25 (+1.51%)
FB   283.29 (+2.23%)
GOOGL   1,598.88 (+0.92%)
AMZN   3,286.33 (+2.47%)
TSLA   424.68 (+1.05%)
NVDA   535.87 (+1.94%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   78.88 (-4.07%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.01 (+0.08%)
NFLX   488.93 (+0.14%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.66 (+0.78%)
AAPL   116.60 (+1.35%)
MSFT   213.25 (+1.51%)
FB   283.29 (+2.23%)
GOOGL   1,598.88 (+0.92%)
AMZN   3,286.33 (+2.47%)
TSLA   424.68 (+1.05%)
NVDA   535.87 (+1.94%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   78.88 (-4.07%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.01 (+0.08%)
NFLX   488.93 (+0.14%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.66 (+0.78%)
AAPL   116.60 (+1.35%)
MSFT   213.25 (+1.51%)
FB   283.29 (+2.23%)
GOOGL   1,598.88 (+0.92%)
AMZN   3,286.33 (+2.47%)
TSLA   424.68 (+1.05%)
NVDA   535.87 (+1.94%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   78.88 (-4.07%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.01 (+0.08%)
NFLX   488.93 (+0.14%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
Log in
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF Stock Forecast, Price & News

$19.16
+0.35 (+1.86 %)
(As of 10/27/2020 04:30 PM ET)
Add
Today's Range
$18.89
Now: $19.16
$19.25
50-Day Range
$16.32
MA: $18.15
$19.88
52-Week Range
$10.16
Now: $19.16
$19.98
Volume20,849 shs
Average Volume24,779 shs
Market Capitalization$68.98 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.
Read More
Global X Genomics & Biotechnology ETF logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:GNOM
CUSIPN/A
Phone+1-650-9432800
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$68.98 million
Next Earnings DateN/A
OptionableNot Optionable
$19.16
+0.35 (+1.86 %)
(As of 10/27/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GNOM News and Ratings via Email

Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Frequently Asked Questions

How has Global X Genomics & Biotechnology ETF's stock price been impacted by COVID-19 (Coronavirus)?

Global X Genomics & Biotechnology ETF's stock was trading at $12.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GNOM shares have increased by 47.8% and is now trading at $19.16.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Sanofi (SNY), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), (MRNA) and Matinas BioPharma (MTNB).

What is Global X Genomics & Biotechnology ETF's stock symbol?

Global X Genomics & Biotechnology ETF trades on the NASDAQ under the ticker symbol "GNOM."

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Global X Genomics & Biotechnology ETF's stock price today?

One share of GNOM stock can currently be purchased for approximately $19.16.

How big of a company is Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF has a market capitalization of $68.98 million.

What is Global X Genomics & Biotechnology ETF's official website?

The official website for Global X Genomics & Biotechnology ETF is www.completegenomics.com.

How can I contact Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF's mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The company can be reached via phone at +1-650-9432800.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.